wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36291060-F647CA2D-49C6-4C8F-A9CF-1A2DEBBA539C
Q36291060-F647CA2D-49C6-4C8F-A9CF-1A2DEBBA539C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36291060-F647CA2D-49C6-4C8F-A9CF-1A2DEBBA539C
Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study
P2860
Q36291060-F647CA2D-49C6-4C8F-A9CF-1A2DEBBA539C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36291060-F647CA2D-49C6-4C8F-A9CF-1A2DEBBA539C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39a281cd452e649ba27a1408a30595f6cbc2b0f5
P2860
Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers.